HomeTLIS • NASDAQ
Follow
Talis Biomedical Corp
Previous close
$8.88
Day range
$8.75 - $8.97
Year range
$4.35 - $9.32
Market cap
15.93M USD
Avg Volume
7.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 140.00K | -82.41% |
Operating expense | 16.86M | -35.41% |
Net income | -15.68M | 39.73% |
Net profit margin | -11.20K | -242.66% |
Earnings per share | — | — |
EBITDA | -16.75M | 26.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 88.00M | -38.80% |
Total assets | 107.23M | -44.75% |
Total liabilities | 25.67M | -38.45% |
Total equity | 81.56M | — |
Shares outstanding | 1.82M | — |
Price to book | 0.20 | — |
Return on assets | -36.84% | — |
Return on capital | -38.89% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -15.68M | 39.73% |
Cash from operations | -11.14M | 46.48% |
Cash from investing | -70.00K | 91.86% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -11.21M | 48.06% |
Free cash flow | -8.10M | 40.33% |
About
Founded
2013
Headquarters
Website
Employees
102